Keyphrases
5-year Survival
20%
Acute Lymphoblastic Leukemia
51%
After Surgery
20%
Bilateral Sagittal Split Osteotomy
23%
Bone Sarcoma
23%
Chemotherapy
29%
Childhood Cancer Survivors
24%
Clinical Outcomes
28%
Clinical Trials
23%
Colorectal Cancer
21%
Colorectal Cancer Surgery
50%
Competing Risks
31%
Confidence Interval
92%
Contact Process
23%
Cumulative Incidence
29%
Distant Metastasis
28%
Dutch
79%
Event-free Survival
40%
Ewing Sarcoma
21%
Extremity Soft Tissue Sarcoma
39%
Hazard Ratio
31%
Health-related Quality of Life
30%
High Risk
35%
Knee
24%
Local Recurrence
35%
Meta-analysis
100%
Minimal Residual Disease
25%
Multistate Model
41%
Netherlands
33%
Neuroblastoma
28%
Odds Ratio
21%
Osteosarcoma
42%
Overall Survival
91%
Pediatric Acute Lymphoblastic Leukemia
24%
Prognostic Factors
51%
Quality of Life
21%
Radiostereometric Analysis
22%
Radiotherapy
34%
Randomized Controlled Trial
35%
Retrospective Cohort Study
20%
Risk Factors
53%
Risk Model
30%
Soft Tissue Sarcoma
38%
Survival Analysis
22%
Systematic Meta-analysis
48%
Total Hip Arthroplasty
25%
Total Hip Replacement
23%
Total Knee Arthroplasty
23%
Tumor
23%
Working Diagnosis
28%
Medicine and Dentistry
Acute Lymphoblastic Leukemia
64%
Biological Marker
19%
Bone Metastasis
34%
Breast Cancer
18%
Cancer Surgery
60%
Chemotherapy
39%
Childhood Cancer
43%
Cohort Analysis
26%
Colorectal Carcinoma
50%
Connective Tissue Cancer
19%
Cumulative Incidence
29%
Dexamethasone
19%
Diagnosis
18%
Disease
40%
Distant Metastasis
27%
Event Free Survival
31%
Ewing Sarcoma
23%
Ganglioneuroblastoma
27%
Hazard Ratio
31%
Hip
25%
Hip Arthroplasty
19%
Hip Replacement
23%
Implant
20%
Knee
30%
Malignant Neoplasm
20%
Meta-Analysis
64%
Metastatic Carcinoma
19%
Minimal Residual Disease
22%
Neoplasm
37%
Oncology
22%
Osteosarcoma
52%
Overall Survival
84%
Pediatrics
48%
Pediatrics Patient
18%
Prognostic Factor
44%
Proportional Hazards Model
37%
Prospective Cohort Study
20%
Prospective Study
18%
Quality of Life
38%
Radiation Therapy
34%
Radiostereometric Analysis
21%
Randomized Controlled Trial
21%
Recurrent Disease
48%
Retrospective Cohort Study
23%
Retrospective Study
21%
Soft Tissue Sarcoma
74%
Surgery
31%
Systematic Review
68%
Total Hip Arthroplasty
20%
Total Knee Arthroplasty
23%